Arkolith/Insider Trading/CATX/Form 4

Williamson Robert F III

DirectorPerspective Therapeutics, Inc. (CATX) · full profile →Form 4 · filed May 30, 2024
Net Buying
Open-Market Buys
$40K
Open-Market Sells
$0
Net Open-Market Flow
$40K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 29, 2024Buy(P)11K$1.32$15K350K
May 29, 2024Buy(P)19K$1.34$25K369K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-066557) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML